The White House has denied that the application was filed on behalf of President Donald Trump.

A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension